Bringing the fundamentals into focus…
Back to Stoke Therapeutics, Inc.
How Stoke Therapeutics, Inc. stacks up
STOK · against 393 other Healthcare companies of similar size
Growth
29/ 100
Below the middle of the pack.
Ranked #277 of 394 · scores higher than 29% of peers
Bars: peers in each 10-point band of the growth score53 peers with a growth score of 20–29, including STOK · Click a bar to see the companies
Why growth scores 29?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 98% of peers. Revenue growth: -86.2% vs peer median 6.1%
- Earnings per share turned from a profit to a loss. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 92% of peers. 3-year revenue growth: 46.1% vs peer median 5.8%
Metric by metric
Position: dot = STOK, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | STOK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 396 reported | -86.2% | 6.4% | 2% | 33% | |
| Earnings per share growthHigher is better · 223 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 385 reported | 46.1% | 7.2% | 92% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around STOK| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 275 | 1.6B USD | 30 | 29 | |
| 277 | 18.9B CNY (≈$2.6B) | 29 | 49 | |
| 277 | 7.1B CNY (≈$994M) | 29 | 54 | |
| 277 | 1.3B USD | 29 | 15 | |
| 277 | 1.7B USD | 29 | 30 | |
| 277 | 996M EUR (≈$1.1B) | 29 | 66 | |
| 282 | 15.1B CNY (≈$2.1B) | 28 | 60 | |
| 282 | 7.7B CNY (≈$1.1B) | 28 | 56 | |
| 282 | 13.2B CNY (≈$1.9B) | 28 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score